Report Detail
Global Erectile Dysfunction Drugs Market Insights, Forecast to 2025
- RnM2734210 |
- 02 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.
The global Erectile Dysfunction Drugs market is valued at 5042.6 million US$ in 2018 and will reach 6583.3 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Erectile Dysfunction Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Erectile Dysfunction Drugs in key regions like North America, Europe, China, South Korea and Israel, focuses on the consumption of Erectile Dysfunction Drugs in these regions.
This research report categorizes the global Erectile Dysfunction Drugs market by top players/brands, region, type and end user. This report also studies the global Erectile Dysfunction Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Erectile Dysfunction Drugs market size by Type
Sildenafil
Tadalafil
Others
In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.
Erectile Dysfunction Drugs market size by Applications
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Erectile Dysfunction Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Erectile Dysfunction Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Erectile Dysfunction Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Erectile Dysfunction Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Erectile Dysfunction Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Pill). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Erectile Dysfunction Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Erectile Dysfunction Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type
- 1.4.2 Sildenafil
- 1.4.3 Tadalafil
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Private Clinics
- 1.5.4 Retail Pharmacies
- 1.5.5 E-Commerce (B2B)
- 1.5.6 E-Commerce (B2C)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Erectile Dysfunction Drugs Market Size
- 2.1.1 Global Erectile Dysfunction Drugs Revenue 2014-2025
- 2.1.2 Global Erectile Dysfunction Drugs Sales 2014-2025
- 2.2 Erectile Dysfunction Drugs Growth Rate by Regions
- 2.2.1 Global Erectile Dysfunction Drugs Sales by Regions
- 2.2.2 Global Erectile Dysfunction Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Erectile Dysfunction Drugs Sales by Manufacturers
- 3.1.1 Erectile Dysfunction Drugs Sales by Manufacturers
- 3.1.2 Erectile Dysfunction Drugs Sales Market Share by Manufacturers
- 3.2 Erectile Dysfunction Drugs Revenue by Manufacturers
- 3.2.1 Erectile Dysfunction Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Erectile Dysfunction Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Erectile Dysfunction Drugs Price by Manufacturers
- 3.4 Erectile Dysfunction Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Erectile Dysfunction Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Erectile Dysfunction Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Erectile Dysfunction Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Erectile Dysfunction Drugs Sales by Type
- 4.2 Global Erectile Dysfunction Drugs Revenue by Type
- 4.3 Erectile Dysfunction Drugs Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Erectile Dysfunction Drugs Breakdown Data by Application
6 North America
- 6.1 North America Erectile Dysfunction Drugs by Country
- 6.1.1 North America Erectile Dysfunction Drugs Sales by Country
- 6.1.2 North America Erectile Dysfunction Drugs Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Erectile Dysfunction Drugs by Type
- 6.3 North America Erectile Dysfunction Drugs by Application
7 Europe
- 7.1 Europe Erectile Dysfunction Drugs by Country
- 7.1.1 Europe Erectile Dysfunction Drugs Sales by Country
- 7.1.2 Europe Erectile Dysfunction Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Erectile Dysfunction Drugs by Type
- 7.3 Europe Erectile Dysfunction Drugs by Application
8 Asia Pacific
- 8.1 Asia Pacific Erectile Dysfunction Drugs by Region
- 8.1.1 Asia Pacific Erectile Dysfunction Drugs Sales by Region
- 8.1.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Thailand
- 8.1.10 Malaysia
- 8.1.11 Philippines
- 8.1.12 Vietnam
- 8.2 Asia Pacific Erectile Dysfunction Drugs by Type
- 8.3 Asia Pacific Erectile Dysfunction Drugs by Application
9 Central & South America
- 9.1 Central & South America Erectile Dysfunction Drugs by Country
- 9.1.1 Central & South America Erectile Dysfunction Drugs Sales by Country
- 9.1.2 Central & South America Erectile Dysfunction Drugs Revenue by Country
- 9.1.3 Brazil
- 9.2 Central & South America Erectile Dysfunction Drugs by Type
- 9.3 Central & South America Erectile Dysfunction Drugs by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Erectile Dysfunction Drugs by Country
- 10.1.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Country
- 10.1.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 GCC Countries
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Erectile Dysfunction Drugs by Type
- 10.3 Middle East and Africa Erectile Dysfunction Drugs by Application
11 Company Profiles
- 11.1 Eli Lilly
- 11.1.1 Eli Lilly Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Eli Lilly Erectile Dysfunction Drugs Products Offered
- 11.1.5 Eli Lilly Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Erectile Dysfunction Drugs Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Bayer
- 11.3.1 Bayer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bayer Erectile Dysfunction Drugs Products Offered
- 11.3.5 Bayer Recent Development
- 11.4 BaiYunShan General Factory
- 11.4.1 BaiYunShan General Factory Company Details
- 11.4.2 Company Business Overview
- 11.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Products Offered
- 11.4.5 BaiYunShan General Factory Recent Development
- 11.5 S.K. Chemicals
- 11.5.1 S.K. Chemicals Company Details
- 11.5.2 Company Business Overview
- 11.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 S.K. Chemicals Erectile Dysfunction Drugs Products Offered
- 11.5.5 S.K. Chemicals Recent Development
- 11.6 Teva Pharma
- 11.6.1 Teva Pharma Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Teva Pharma Erectile Dysfunction Drugs Products Offered
- 11.6.5 Teva Pharma Recent Development
- 11.7 Dong-A ST
- 11.7.1 Dong-A ST Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Dong-A ST Erectile Dysfunction Drugs Products Offered
- 11.7.5 Dong-A ST Recent Development
- 11.8 Metuchen Pharma
- 11.8.1 Metuchen Pharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Metuchen Pharma Erectile Dysfunction Drugs Products Offered
- 11.8.5 Metuchen Pharma Recent Development
- 11.9 Seoul Pharma
- 11.9.1 Seoul Pharma Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Seoul Pharma Erectile Dysfunction Drugs Products Offered
- 11.9.5 Seoul Pharma Recent Development
- 11.10 CSBIO.
- 11.10.1 CSBIO. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 CSBIO. Erectile Dysfunction Drugs Products Offered
- 11.10.5 CSBIO. Recent Development
12 Future Forecast
- 12.1 Erectile Dysfunction Drugs Market Forecast by Regions
- 12.1.1 Global Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Erectile Dysfunction Drugs Market Forecast by Type
- 12.2.1 Global Erectile Dysfunction Drugs Sales Forecast by Type 2019-2025
- 12.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type 2019-2025
- 12.3 Erectile Dysfunction Drugs Market Forecast by Application
- 12.4 North America Erectile Dysfunction Drugs Forecast
- 12.5 Europe Erectile Dysfunction Drugs Forecast
- 12.6 Asia Pacific Erectile Dysfunction Drugs Forecast
- 12.7 Central & South America Erectile Dysfunction Drugs Forecast
- 12.8 Middle East and Africa Erectile Dysfunction Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Erectile Dysfunction Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Erectile Dysfunction Drugs . Industry analysis & Market Report on Erectile Dysfunction Drugs is a syndicated market report, published as Global Erectile Dysfunction Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Erectile Dysfunction Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
